Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 34,505 | 28,267 | 32,100 | 21,766 | 0 |
| Gross Profit | 34,505 | 28,267 | 32,100 | 21,766 | N/A |
| Operating Expenses | 106,381 | 128,551 | 123,495 | 114,605 | 54,856 |
| Operating Income | -71,876 | -100,284 | -91,395 | -92,839 | -54,856 |
| Interest Expense | 502 | 0 | 0 | 0 | 0 |
| Other Income | 2,099 | 1,342 | 2,015 | 1,260 | 76 |
| Pre-tax Income | -70,279 | -98,942 | -89,380 | -91,579 | -54,780 |
| Net Income Continuous | -70,279 | -98,942 | -89,380 | -91,579 | -54,780 |
| Net Income | $-70,279 | $-98,942 | $-89,380 | $-91,579 | $-54,780 |
| EPS Basic Total Ops | -24.80 | -48.60 | -44.20 | -46.00 | -46.60 |
| EPS Basic Continuous Ops | -24.81 | -48.57 | -44.19 | -45.97 | -46.56 |
| EPS Diluted Total Ops | -24.80 | -48.60 | -44.20 | -46.00 | -46.60 |
| EPS Diluted Continuous Ops | -24.81 | -48.57 | -44.19 | -45.97 | -46.56 |
| EPS Diluted Before Non-Recurring Items | -24.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-64,164 | $-92,636 | $-84,352 | $-89,020 | $-54,128 |